NCT01179022

Brief Summary

Incidence of Bacteremia Following Argon Plasma Coagulation in Patients with Endobronchial Lesions

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 10, 2010

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2010

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
Last Updated

March 13, 2013

Status Verified

March 1, 2012

Enrollment Period

2 years

First QC Date

August 8, 2010

Last Update Submit

March 12, 2013

Conditions

Keywords

BacteremiaArgon Plasma CoagulationEndobronchial Lesions

Outcome Measures

Primary Outcomes (1)

  • The bacteremic rate following APC in patients with endobronchial involvment.

    Two years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

50 patients that undergo bronchoscopy with the use of APC

You may qualify if:

  • All patients that undergo bronchoscopy with the use of APC

You may not qualify if:

  • All patients under 18 years old All Patients with evidence of current respiratory infection or febrile illnesses and those that will receive antibiotic therapy within a week prior to the bronchoscopy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Meir MC

Kfar Saba, Israel, 49100, Israel

Location

Related Publications (1)

  • Matveychuk A, Guber A, Talker O, Shitrit D. Incidence of bacteremia following bronchoscopy with argon plasma coagulation: a prospective study. Lung. 2014 Aug;192(4):615-8. doi: 10.1007/s00408-014-9583-8. Epub 2014 Apr 27.

MeSH Terms

Conditions

Bacteremia

Condition Hierarchy (Ancestors)

Bacterial InfectionsBacterial Infections and MycosesInfectionsSepsisSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • DAVID SHITRIT, MD

    Meir Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2010

First Posted

August 10, 2010

Study Start

October 1, 2010

Primary Completion

October 1, 2012

Study Completion

October 1, 2012

Last Updated

March 13, 2013

Record last verified: 2012-03

Locations